Clinical Trial Update: High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy [NA]

View source ↗

Summary

Completed clinical trial evaluating high-density wave mapping to predict atrial fibrillation recurrence after a single ablation using a pulmonary vein isolation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia

Snippet

Sponsor: Abbott Medical Devices | Conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2024-09-19